Back to Man Group plc Man Group plc

AMLXAMLX

Showing 4 of 6 quarters

Position history for Man Group plcMan Group plc's holdings in Amylyx Pharmaceuticals, Inc.

No. Man Group exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 87,352 shares worth $309,226. Man Group first reported AMLX in Q1 2024 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$423,993

Total Shares Change

-130,862

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$6.33
0
2025-Q1
Decreased
87,352
-12.7%
$309,2260.0%$3.66
0
2024-Q4
Decreased
100,059
-23.5%
$378,2230.0%$3.84
0
2024-Q3
Increased
130,862
+12.7%
$423,9930.0%$3.08
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used